Press Releases

December 31, 2017
NeoGenomics Featured in the Canton of Vaud Annual Report

December 6, 2017
NeoGenomics Announces Six Clinical Data Presentations to be Given at the American Society of Hematology Meeting

December 5, 2017
NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine^™ Dx Target Test

November 9, 2017
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials

October 25, 2017
NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017

October 24, 2017
NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials

October 12, 2017
NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance

September 28, 2017
NeoGenomics Schedules its Q3 2017 Earnings Release for October 25, 2017

September 11, 2017
NeoGenomics Reports on Impacts from Hurricane Irma

July 25, 2017
NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017

June 28, 2017
NeoGenomics Schedules its Q2 2017 Earnings Release for July 25, 2017

June 2, 2017
NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests

May 15, 2017
NeoGenomics Reports that its NeoLAB^® Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer

April 26, 2017
NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017

April 20, 2017
NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development

April 14, 2017
NeoGenomics Schedules its Q1 2017 Earnings Release for April 26, 2017

March 13, 2017
NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing

February 22, 2017
NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016

February 8, 2017
NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017

December 22, 2016
NeoGenomics Closes $150 Million Senior Credit Facility

October 26, 2016
NeoGenomics Reports 142% Revenue Growth to $60.8 Million and a Record $9.6 Million in Cash Flow from Operations in the Third Quarter of 2016

October 11, 2016
NeoGenomics Schedules its Q3 2016 Earnings Release for October 26, 2016

Jul 26, 2016
NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016

Jul 5, 2016
NeoGenomics Schedules its Q2 2016 Earnings Release for July 26, 2016

Apr 27, 2016
NeoGenomics Reports 159% Revenue Growth to $59.7 Million and 442% Adjusted EBITDA Increase to $8.2 Million, Driven by Clarient Acquisition and Strong Volume Gains

Apr 11, 2016
NeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016

Mar 1, 2016
NeoGenomics Reports Record Revenue of $27.2 Million and Record Adjusted EBITDA of $2.9 Million in Fourth Quarter, Driven by Strong Volume Gains

Jan 26, 2016
NeoGenomics Schedules its Q4 2015 and Full Year 2015 Earnings Release for March 1, 2016

Dec 30, 2015
NeoGenomics Completes Acquisition of Clarient, Inc.

Dec 8, 2015
NeoGenomics Launches New Liquid Biopsy Tests for Monitoring Solid Tumors and Predicting Resistance to BTK Inhibitors

Oct 29, 2015
NeoGenomics Reports Revenue of $25.1 Million and Record Adjusted EBITDA of $2.8 Million Driven by a 25% Increase in Test Volume in the Third Quarter of 2015

Oct 28, 2015
NeoGenomics Amends Strategic Alliance Agreement with Covance Central Laboratory Services

Oct 21, 2015
NeoGenomics Signs Definitive Agreement to Acquire Clarient, Inc.

Oct 12, 2015
NeoGenomics Schedules its Q3 2015 Earnings Release for October 29, 2015

Sep 23, 2015
NeoGenomics Launches New NeoSITE™ Cervical FISH Assay for Evaluation of Abnormal Pap Tests

Sep 2, 2015
NeoGenomics Enters Into National Agreement with Premier, Inc. to Offer Cancer Genetics Testing Services to 3,600 Hospitals